Tata Chemicals quarterly results

·ChemicalsChart ›
Q1 FY27 · Apr–Jun 2026
₹ croreQ1 FY27Q1 FY26Change
Revenue4,2553,719+14.4%
EBITDA555649−14.5%
EBITDA margin13.0%17.5%−4.4 pts
Profit before tax127318−60.1%
Net profit60.0316−81.0%
EPS−₹0.67₹9.89—

Every quarter

₹ crore except per share
Tap a line for its trendQ1 FY27Jun 2026Q4 FY26Mar 2026Q3 FY26Dec 2025Q2 FY26Sep 2025Q1 FY26Jun 2025Q4 FY25Mar 2025Q3 FY25Dec 2024Q2 FY25Sep 2024Q1 FY25Jun 2024Q4 FY24Mar 2024Q3 FY24Dec 2023Q2 FY24Sep 2023Earlier quartersAlpha Plus
4,2553,4383,5503,8773,7193,5093,5903,9993,7893,4753,7303,998
Earlier quartersEvery year the company has filed comes with Alpha Plus.
56.044.038.013896.042.028.010847.011438.085.0
4,3113,4823,5884,0153,8153,5513,6184,1073,8363,5893,7684,083
Expenses
887688710733827580657714609625649734
14656.033.068.014884.061.040.0105−16.040.056.0
−174−73.069.0167−24245.0−20410384.0−1328.029.0
545524505514517484527501477479469454
148153146144147137148145133130132145
336343293285280293280277273271246234
2,2961,9691,8881,8581,8201,9892,1152,0231,9402,0762,0221,906
4,1843,6603,6443,7693,4973,6123,5843,8033,6213,4333,5663,558
555274345537649327434618574443542819
219−69.052.025236934.0154341301172296585
Profit
127−178−56.0246318−61.034.0304215156202525
0.0−1,837−54.0−65.00.0−55.0−70.00.00.0−9630.0102
127−2,015−110181318−116−36.0304215−807202627
70.019.020.055.078.0−34.013.069.078.02.052.063.0
−20.0115−24.027.0−34.09.04.012.016.020.016.057.0
50.0134−4.082.044.0−25.017.081.094.022.068.0120
−17.033.037.055.042.024.032.044.054.011.060.0−12.0
60.0−2,116−69.0154316−49.0−21.0267190−841194495
77.0−2,149−10699.0274−91.0−53.0223121−829134507
0.00.00.00.00.018.00.00.015.0−23.00.00.0
887123953−7.0721−30.0−462359−368697833364
947−1,9938841471,037−79.0−483626−178−1441,027859
−17.0−2,132−93.077.0252−56.0−53.0194150−850158428
77.016.024.077.064.07.032.073.040.09.036.067.0
Per share
−₹0.67−₹83.68₹3.65₹3.02₹9.89−₹2.19−₹2.08₹7.61₹5.89−₹33.36₹6.20₹16.80
−₹0.67−₹83.68₹3.65₹3.02₹9.89−₹2.19−₹2.08₹7.61₹5.89−₹33.36₹6.20₹16.80
Continuing & discontinued operations
0.00.00.00.00.027.00.00.020.0−23.00.00.0
0.00.00.00.00.09.00.00.05.00.00.00.0
Other comprehensive income — detail
887123953−7.0721−30.0——————
990−408941−379882−24.0−836618−426824934290
67.0−45.084.0−56.01260.0——————
——————−99.0229−50.014399.027.0
−31.048794.0313−36.0−1.0280−31.010.042.0−12.0105
5.01.0−2.0−3.0−1.05.0——————
——————5.0−1.02.026.0−10.04.0
871−2,01185970.0974−85.0−516553−217−153991792
76.018.025.077.063.06.033.073.039.09.036.067.0
Per share — as-filed variants
−₹0.67−₹83.68₹3.65₹3.02₹9.89−₹2.90−₹2.08₹7.61₹5.30−₹32.46₹6.20₹16.80
−₹0.67−₹83.68₹3.65₹3.02₹9.89−₹2.90−₹2.08₹7.61₹5.30−₹32.46₹6.20₹16.80
₹0.00₹0.00₹0.00₹0.00₹0.00₹0.71₹0.00₹0.00₹0.59−₹0.90₹0.00₹0.00
₹0.00₹0.00₹0.00₹0.00₹0.00₹0.71₹0.00₹0.00₹0.59−₹0.90₹0.00₹0.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
3,3962,7672,7382,9092,9862,8003,0763,1422,9912,9983,0333,179
79.8%80.5%77.1%75.0%80.3%79.8%85.7%78.6%78.9%86.3%81.3%79.5%
Adjusted (ex-exceptional items) — derived
127−178−56.0246318−61.034.0304215156202525
0.0−1,837−54.0−65.00.0−55.0−70.00.00.0−9630.0102
60.0−279−17.0190316−5.949.0267190122194413
−₹0.67−₹11.03₹0.90₹3.72₹9.89−₹0.26₹4.85₹7.61₹5.89₹4.84₹6.20₹14.00
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

TATACHEM₹603.45

Tata Chemicals Ltd.

· Chemicals
AnnualQuarterly₹ CrorePeersGHCLAARTIINDJGCHEMCHAMBLFERTNAVINFLUORDEEPAKFERTHSCLNOCILMcap ₹15,388 Cr
View
In ₹ Crore except Per Share
3 Months Ending
Q2 FY24
30/09/2023
Q3 FY24
31/12/2023
Q4 FY24
31/03/2024
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations3,998.03,730.03,475.03,789.03,999.03,590.03,509.03,719.03,877.03,550.03,438.04,255.0
Other Income85.038.0114.047.0108.028.042.096.0138.038.044.056.0
Total Income4,083.03,768.03,589.03,836.04,107.03,618.03,551.03,815.04,015.03,588.03,482.04,311.0
Expenses
+ Cost of Materials Consumed734.0649.0625.0609.0714.0657.0580.0827.0733.0710.0688.0887.0
+ Purchases of Stock-in-Trade56.040.0-16.0105.040.061.084.0148.068.033.056.0146.0
+ Changes in Inventories29.08.0-132.084.0103.0-204.045.0-242.0167.069.0-73.0-174.0
+ Employee Benefit Expense454.0469.0479.0477.0501.0527.0484.0517.0514.0505.0524.0545.0
+ Finance Costs145.0132.0130.0133.0145.0148.0137.0147.0144.0146.0153.0148.0
+ Depreciation & Amortisation234.0246.0271.0273.0277.0280.0293.0280.0285.0293.0343.0336.0
+ Other Expenses1,906.02,022.02,076.01,940.02,023.02,115.01,989.01,820.01,858.01,888.01,969.02,296.0
Total Expenses3,558.03,566.03,433.03,621.03,803.03,584.03,612.03,497.03,769.03,644.03,660.04,184.0
EBITDA819.0542.0443.0574.0618.0434.0327.0649.0537.0345.0274.0555.0
EBIT585.0296.0172.0301.0341.0154.034.0369.0252.052.0-69.0219.0
Profit
PBT before Exceptional Items525.0202.0156.0215.0304.034.0-61.0318.0246.0-56.0-178.0127.0
+ Exceptional Items102.00.0-963.00.00.0-70.0-55.00.0-65.0-54.0-1,837.00.0
Pretax Income627.0202.0-807.0215.0304.0-36.0-116.0318.0181.0-110.0-2,015.0127.0
+ Current Tax63.052.02.078.069.013.0-34.078.055.020.019.070.0
+ Deferred Tax57.016.020.016.012.04.09.0-34.027.0-24.0115.0-20.0
Tax Expense120.068.022.094.081.017.0-25.044.082.0-4.0134.050.0
+ Share of Associates & JVs-12.060.011.054.044.032.024.042.055.037.033.0-17.0
Net Income495.0194.0-841.0190.0267.0-21.0-49.0316.0154.0-69.0-2,116.060.0
+ Net Income — Continuing Ops507.0134.0-829.0121.0223.0-53.0-91.0274.099.0-106.0-2,149.077.0
+ Net Income — Discontinued Ops0.00.0-23.015.00.00.018.00.00.00.00.00.0
+ Other Comprehensive Income364.0833.0697.0-368.0359.0-462.0-30.0721.0-7.0953.0123.0887.0
Total Comprehensive Income859.01,027.0-144.0-178.0626.0-483.0-79.01,037.0147.0884.0-1,993.0947.0
Net Income to Common428.0158.0-850.0150.0194.0-53.0-56.0252.077.0-93.0-2,132.0-17.0
Minority Interest67.036.09.040.073.032.07.064.077.024.016.077.0
Per Share
Basic EPS16.806.20-33.365.897.61-2.08-2.199.893.023.65-83.68-0.67
Diluted EPS16.806.20-33.365.897.61-2.08-2.199.893.023.65-83.68-0.67
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax0.00.0-23.020.00.00.027.00.00.00.00.00.0
+ Tax — Discontinued Operations0.00.00.05.00.00.09.00.00.00.00.00.0
Other Comprehensive Income — detail
+ Other Comprehensive Income——————-30.0721.0-7.0953.0123.0887.0
+ Items NOT to be Reclassified to P&L290.0934.0824.0-426.0618.0-836.0-24.0882.0-379.0941.0-408.0990.0
+ Tax on Items NOT to be Reclassified——————0.0126.0-56.084.0-45.067.0
+ Tax on Items NOT to be Reclassified — alt tag27.099.0143.0-50.0229.0-99.0——————
+ Items to be Reclassified to P&L105.0-12.042.010.0-31.0280.0-1.0-36.0313.094.0487.0-31.0
+ Tax on Items to be Reclassified——————5.0-1.0-3.0-2.01.05.0
+ Tax on Items to be Reclassified — alt tag4.0-10.026.02.0-1.05.0——————
Comprehensive Income — Owners of Parent792.0991.0-153.0-217.0553.0-516.0-85.0974.070.0859.0-2,011.0871.0
Comprehensive Income — Non-controlling Interests67.036.09.039.073.033.06.063.077.025.018.076.0
Per Share — as-filed variants
Basic EPS — Continuing Operations16.806.20-32.465.307.61-2.08-2.909.893.023.65-83.68-0.67
Diluted EPS — Continuing Operations16.806.20-32.465.307.61-2.08-2.909.893.023.65-83.68-0.67
Basic EPS — Discontinued Operations0.000.00-0.900.590.000.000.710.000.000.000.000.00
Diluted EPS — Discontinued Operations0.000.00-0.900.590.000.000.710.000.000.000.000.00
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit3,179.03,033.02,998.02,991.03,142.03,076.02,800.02,986.02,909.02,738.02,767.03,396.0
Gross Margin %79.5181.3186.2778.9478.5785.6879.7980.2975.0377.1380.4879.81
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)525.0202.0156.0215.0304.034.0-61.0318.0246.0-56.0-178.0127.0
− Exceptional Items (reconciliation)102.00.0-963.00.00.0-70.0-55.00.0-65.0-54.0-1,837.00.0
Net Income Adj (tax-effected)412.5194.0122.0190.0267.049.0-5.9316.0189.6-17.0-279.060.0
EPS Adj14.006.204.845.897.614.85-0.269.893.720.90-11.03-0.67
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.00
Filed Debt Equity————0.000.00—0.31————
Filed Dscr————3.00——3.88————
Filed Iscr————4.003.00—4.41————
Paid Up Equity Capital255.0255.0255.0255.0255.0255.0255.0255.0255.0255.0255.0255.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Tata Chemicals Q2 FY27 results date

Tata Chemicals (NSE: TATACHEM) will announce its Q2 FY27 results (July–September 2026) on Saturday, 7 November 2026, according to the board-meeting notice it filed on 28 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net loss attributable to shareholders was ₹17 crore, against a profit of ₹252 crore in Q1 FY26 and narrower than the loss of ₹2,132 crore in Q4 FY26. Revenue from operations was ₹4,255 crore, up 14.4% year on year and up 23.8% from the previous quarter.

Board-meeting notice filed
28 October 2026
Q2 FY26 results (a year earlier)
1 November 2025
Q1 FY27 results (the latest)
27 July 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results date
7 November 2026Saturday · notice filed 28 Oct
Q1 FY27 net loss
−₹17 Crprofit ₹252 Cr in Q1 FY26loss ₹2,132 Cr in Q4 FY26
Q1 FY27 revenue
₹4,255 Cr+14.4% vs Q1 FY26+23.8% vs Q4 FY26
Q1 FY27 operating margin
5.1%−4.8 pts vs Q1 FY26+7.2 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier)
₹77 CrRevenue ₹3,877 Cr
Q1 FY27 EPS (basic)
−₹0.67

Questions

When will Tata Chemicals announce its Q2 FY27 results?

On 7 November 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 28 October 2026). Last year it reported Q2 FY26 on 1 November 2025.

What were Tata Chemicals' Q1 FY27 results?

Consolidated net loss attributable to shareholders was ₹17 crore, against a profit of ₹252 crore in Q1 FY26 and narrower than the loss of ₹2,132 crore in Q4 FY26. Revenue from operations was ₹4,255 crore, up 14.4% year on year and up 23.8% from the previous quarter.

What was Tata Chemicals' net profit in FY26?

Consolidated net profit attributable to shareholders was a loss of ₹1,896 crore in FY26 (April 2025–March 2026), against a profit of ₹235 crore in FY25. It was a profit of ₹268 crore in FY24 and a profit of ₹2,317 crore in FY23.

What will Tata Chemicals' Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit attributable to shareholders was ₹77 crore and revenue from operations ₹3,877 crore. The latest quarter, Q1 FY27, had a net loss of ₹17 crore and revenue of ₹4,255 crore.

How has Tata Chemicals' profit changed over the last four quarters?

Net profit attributable to shareholders by quarter: a profit of ₹77 crore in Q2 FY26, a loss of ₹93 crore in Q3 FY26, a loss of ₹2,132 crore in Q4 FY26 and a loss of ₹17 crore in Q1 FY27. That is a combined loss of ₹2,165 crore over the four quarters. Revenue from operations: ₹3,877 crore, ₹3,550 crore, ₹3,438 crore and ₹4,255 crore.

What was Tata Chemicals' revenue in FY26?

Revenue from operations was ₹14,584 crore in FY26 (April 2025–March 2026), down 2.0% from ₹14,887 crore in FY25. It was ₹15,421 crore in FY24 and ₹16,789 crore in FY23: down 13.1% over three years, an average fall of 4.6% a year.

Where do these Tata Chemicals figures come from?

From Tata Chemicals' own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.